Literature DB >> 33751222

A systemic apolipoprotein A-IV-associated amyloidosis confirmed by proteome analysis.

Taro Murakami1, Akira Takasawa2, Asako Moriki1,3, Yusuke Igaki4, Hiroshi Ikeda5, Kazuyuki Murase5, Kohichi Takada5, Kazufumi Magara1, Tomoyuki Aoyama1, Yusuke Ono1, Daisuke Kyuno1, Kumi Takasawa1, Masaki Murata1,6, Makoto Osanai1.   

Abstract

Amyloidosis is induced by extracellular deposition of certain proteins. Thirty-six proteins have so far been identified as amyloidogenic proteins in humans. Although it is very important to determine the specific amyloid protein type for the choice of therapy for amyloidosis patient, it might be difficult to identify specific proteins from amyloid-deposited tissue. Apolipoprotein A-IV is known as an amyloid-associated protein, but there have been few reports of apolipoprotein A-IV amyloidosis. Here we report a case of systemic apolipoprotein A-IV-associated amyloidosis that was confirmed by proteome analysis using formalin-fixed paraffin-embedded tissue and an immunohistochemical technique.

Entities:  

Keywords:  Amyloidosis; Apolipoprotein A-IV; Formalin-fixed paraffin-embedded tissue; Proteome analysis

Year:  2021        PMID: 33751222     DOI: 10.1007/s00428-021-03073-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

1.  Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis.

Authors:  J Bergström; C Murphy; M Eulitz; D T Weiss; G T Westermark; A Solomon; P Westermark
Journal:  Biochem Biophys Res Commun       Date:  2001-07-27       Impact factor: 3.575

Review 2.  How to diagnose amyloidosis.

Authors:  P Mollee; P Renaut; D Gottlieb; H Goodman
Journal:  Intern Med J       Date:  2014-01       Impact factor: 2.048

3.  Immunoreactivity patterns of tight junction proteins are useful for differential diagnosis of human salivary gland tumors.

Authors:  Tomoyuki Aoyama; Akira Takasawa; Masaki Murata; Makoto Osanai; Kenichi Takano; Tadashi Hasagawa; Norimasa Sawada
Journal:  Med Mol Morphol       Date:  2018-06-28       Impact factor: 2.309

Review 4.  Systemic amyloidosis.

Authors:  Ashutosh D Wechalekar; Julian D Gillmore; Philip N Hawkins
Journal:  Lancet       Date:  2015-12-21       Impact factor: 79.321

5.  Medullary amyloidosis associated with apolipoprotein A-IV deposition.

Authors:  Sanjeev Sethi; Jason D Theis; Shirley M Shiller; Cynthia C Nast; David Harrison; Helmut G Rennke; Julie A Vrana; Ahmet Dogan
Journal:  Kidney Int       Date:  2011-09-07       Impact factor: 10.612

6.  Two different types of amyloid deposits--apolipoprotein A-IV and transthyretin--in a patient with systemic amyloidosis.

Authors:  Joakim Bergström; Charles L Murphy; Deborah T Weiss; Alan Solomon; Knut Sletten; Ulf Hellman; Per Westermark
Journal:  Lab Invest       Date:  2004-08       Impact factor: 5.662

7.  Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis.

Authors:  Surendra Dasari; Md Shahrier Amin; Paul J Kurtin; Julie A Vrana; Jason D Theis; Karen L Grogg; Mariam P Alexander; Samih H Nasr; Fernando C Fervenza; Nelson Leung; Sanjeev Sethi
Journal:  Kidney Int       Date:  2016-06-02       Impact factor: 10.612

Review 8.  Human amyloidosis, still intractable but becoming curable: The essential role of pathological diagnosis in the selection of type-specific therapeutics.

Authors:  Hironobu Naiki; Yoshiki Sekijima; Mitsuharu Ueda; Kenichi Ohashi; Yoshinobu Hoshii; Masayuki Shimoda; Yukio Ando
Journal:  Pathol Int       Date:  2020-01-21       Impact factor: 2.534

Review 9.  Apolipoprotein A-IV: A Multifunctional Protein Involved in Protection against Atherosclerosis and Diabetes.

Authors:  Jie Qu; Chih-Wei Ko; Patrick Tso; Aditi Bhargava
Journal:  Cells       Date:  2019-04-05       Impact factor: 6.600

10.  Aldolase A promotes epithelial-mesenchymal transition to increase malignant potentials of cervical adenocarcinoma.

Authors:  Yuki Saito; Akira Takasawa; Kumi Takasawa; Tomoyuki Aoyama; Taishi Akimoto; Misaki Ota; Kazufumi Magara; Masaki Murata; Yoshihiko Hirohashi; Tadashi Hasegawa; Norimasa Sawada; Tsuyoshi Saito; Makoto Osanai
Journal:  Cancer Sci       Date:  2020-06-30       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.